Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults

Helen Ward, Christina Atchison, Matthew Whitaker, Kylie EC Ainslie, Joshua Elliott, Lucy Okell, Rozlyn Redd, Deborah Ashby, Christl A Donnelly, Wendy Barclay, Ara Darzi, Graham Cooke, Steven Riley, Paul Elliott
doi: https://doi.org/10.1101/2020.08.12.20173690

Article Information

doi 
https://doi.org/10.1101/2020.08.12.20173690
History 
  • August 21, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Helen Ward, PhD.1,
  2. Christina Atchison, PhD.2,
  3. Matthew Whitaker, MSc.3,
  4. Kylie EC Ainslie, PhD.4,
  5. Joshua Elliott, MBBS.5,
  6. Lucy Okell, PhD.6,
  7. Rozlyn Redd, PhD.7,
  8. Deborah Ashby, PhD.8,
  9. Christl A Donnelly, PhD.9,
  10. Wendy Barclay, PhD.10,
  11. Ara Darzi, PhD.11,
  12. Graham Cooke, PhD.12,
  13. Steven Riley, PhD.13 and
  14. Paul Elliott, PhD.14,*
  1. 1School of Public Health, Imperial College London; Imperial College Healthcare NHS Trust; National Institute for Health Research Imperial Biomedical Research Centre
  2. 2School of Public Health, Imperial College London; Imperial College Healthcare NHS Trust
  3. 3School of Public Health, Imperial College London
  4. 4School of Public Health, Imperial College London; MRC Centre for Global Infectious Disease Analysis Imperial College London
  5. 5School of Public Health, Imperial College London
  6. 6School of Public Health, Imperial College London; MRC Centre for Global Infectious Disease Analysis Imperial College London
  7. 7School of Public Health, Imperial College London
  8. 8School of Public Health, Imperial College London
  9. 9School of Public Health, Imperial College London; MRC Centre for Global Infectious Disease Analysis, Imperial College London; Department of Statistics, University of Oxford
  10. 10Department of Infectious Disease, Imperial College London; Imperial College Healthcare NHS Trust
  11. 11Institute of Global Health Innovation, Imperial College London; Imperial College Healthcare NHS Trust
  12. 12Department of Infectious Disease, Imperial College London; Imperial College Healthcare NHS Trust; National Institute for Health Research Imperial Biomedical Research Centre
  13. 13School of Public Health, Imperial College London; MRC Centre for Global Infectious Disease Analysis, Imperial College London
  14. 14School of Public Health, Imperial College London; Imperial College Healthcare NHS Trust; National Institute for Health Research Imperial Biomedical Research Centre; MRC Centre for Environment and Health, Imperial College London
  1. ↵* CORRESPONDING AUTHOR
    Professor Paul Elliott, Address: School of Public Health, Imperial College London, London W2 1PG, UK, Email: p.elliott{at}imperial.ac.uk, Phone:+44 78 41 95 15 59
Back to top
Posted August 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults
Helen Ward, Christina Atchison, Matthew Whitaker, Kylie EC Ainslie, Joshua Elliott, Lucy Okell, Rozlyn Redd, Deborah Ashby, Christl A Donnelly, Wendy Barclay, Ara Darzi, Graham Cooke, Steven Riley, Paul Elliott
medRxiv 2020.08.12.20173690; doi: https://doi.org/10.1101/2020.08.12.20173690
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area